What is HARBIN GLORIA PHARMACEUTICALS Co., LTD's (002437.SZ) StockRank?

MoatMap's StockRank for HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) is 73/100, with a Buy signal. This is a composite score combining Quality (71), Value (38), and Momentum (50) factor ranks across MoatMap's 19,000+ stock universe.

Does HARBIN GLORIA PHARMACEUTICALS Co., LTD have an economic moat?

HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is HARBIN GLORIA PHARMACEUTICALS Co., LTD a buy, hold, or sell?

MoatMap's current signal for HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) is Buy, based on a StockRank of 73/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is HARBIN GLORIA PHARMACEUTICALS Co., LTD in?

HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002437.SZ

BUYREMOVE

HARBIN GLORIA PHARMACEUTICALS Co., LTD · Healthcare · China · $975M · Avg Vol: $21M/d

StockRank

P/E (TTM)

14.8x

ROE

19.1%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Harbin Gloria Pharmaceuticals is a domestic Chinese pharmaceutical player. It does not possess the global scale, regulatory validation, or advanced biologics capabilities to ride the CDMO pricing power cycle.

COMPANY DESCRIPTION

Harbin Gloria Pharmaceuticals specializes in the research, development, and manufacture of specialty and generic pharmaceuticals, with a core focus on cardiovascular, cerebrovascular, and oncology treatments. The company maintains a strong market position in China through its extensive hospital distribution network and a robust portfolio of proprietary traditional Chinese medicine injections. It operates as a key niche player in the domestic specialty drug market, supported by integrated manufacturing capabilities.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	459M	388M	361M	316M	-11.8%
EPS	-0.02	0.01	0.02	0.03	77.3%
Shares	2.2B	2.2B	2.3B	2.2B	+1.5%
Debt	215M	100M	484,932	14M	-60.2%
Equity	241M	246M	288M	339M	12.0%
Op CF	39M	41M	61M	40M	1.5%
Inv CF	-33M	14M	-9M	-49M	—
Fin CF	-31M	-131M	-86M	-4M	—

PRICE (1M)-22.6%

SMA 50SMA 200

$0.39

RSI (14)

16.3

52W High

$0.60

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

17.6%89.5

ROE

19.1%87.8

GP/Assets

30.2%65.7

Op. Margin

14.1%73.4

FCF/Assets

1.2%55.1

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.01x89.0

Current Ratio

1.90x35.2

Value

P/E (TTM)

14.8x73.5

EV/EBITDA

15.4x26.9

P/FCF

1169.0x7.2

P/B

2.5x46.7

P/S

2.8x58.8

Div Yield

—N/A

Momentum

52W High %

65%48.2

RS 6M

-26%47.2

SMA 50/200

0.99x60.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

57%78.8

FUNDAMENTALS

Market Cap

$975M

P/E (Forward)

—

Gross Margin

44.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002437.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002437.SZ	HARBIN GLORIA PHARMACEUTICALS Co., LTD(you)	$975M	73	BUY
603439.SS	Guizhou Sanli Pharmaceutical Co.,Ltd	$984M	70	BUY
300705.SZ	Hunan Jiudian Pharmaceutical Co., Ltd.	$869M	70	BUY
300039.SZ	Shanghai Kaibao Pharmaceutical CO.,Ltd	$822M	68	BUY
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD
603367.SS	Cisen Pharmaceutical Co., Ltd.	$934M	81	STRONG BUY
600557.SS	Jiangsu Kanion Pharmaceutical Co.,Ltd.	$1.1B	65	HOLD
002390.SZ	Guizhou Xinbang Pharmaceutical Co., Ltd.	$870M	81	STRONG BUY
002550.SZ	Changzhou Qianhong Biopharma CO.,LTD	$1.2B	66	BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) — Stock Score Summary

HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) has a MoatMap StockRank of 73/100 based on Quality (71/100), Value (38/100), and Momentum (50/100) factor scores. The current signal is BUY. Harbin Gloria Pharmaceuticals is a domestic Chinese pharmaceutical player. It does not possess the global scale, regulatory validation, or advanced biologics capabilities to ride the CDMO pricing power cycle.

Key Financial Metrics

Price	$0.39
Market Cap	$975M
P/E (TTM)	14.83
Price/Book	2.49
Return on Equity	19.1%
Return on Invested Capital	17.6%
Debt/Equity	0.90
Gross Margin	44.4%
Operating Margin	14.1%
Revenue Growth	-2.2%
Free Cash Flow	$834K

HARBIN GLORIA PHARMACEUTICALS Co., LTD operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is HARBIN GLORIA PHARMACEUTICALS Co., LTD’s (002437.SZ) StockRank?: MoatMap’s StockRank for HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) is 73/100, with a Buy signal. It is a composite of Quality (71), Value (38), and Momentum (50) factor ranks across MoatMap’s 19,000+ stock universe.
Does HARBIN GLORIA PHARMACEUTICALS Co., LTD have an economic moat?: HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is HARBIN GLORIA PHARMACEUTICALS Co., LTD a buy, hold, or sell?: MoatMap’s current signal for HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) is Buy, based on a StockRank of 73/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is HARBIN GLORIA PHARMACEUTICALS Co., LTD in?: HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).